<DOC>
	<DOCNO>NCT02506335</DOCNO>
	<brief_summary>Background : It still difficult predict outcome patient require Fontan Revisions evidence congestive hepatopathy probable cirrhosis require major cardiac surgery include heart transplant . Over year , many prognostic index derive laboratory result blood test , clinical physiological variable ( combination thereof ) , liver image liver histology , issue sample error , medical risk technical difficulty . None prove entirely satisfactory . Predicting morbidity survival particularly important decide Fontan revision versus need heart transplantation . What need truly reliable test liver function help predict outcome , basis single measurement within day plan revision . For purpose , desirable chosen test liver performance safe , non-invasive , easy perform , rapid turnaround result , readily repeatable . Tests hepatic elimination various exogenous substance describe , galactose elimination capacity ( GEC ) , indocyanine green ( ICG ) clearance , lidocaine metabolism monoethylglycinexylidide ( MEGX ) , test rely liver metabolic capacity . None metabolic clearance test achieve widespread acceptance use , mostly performance analyse cumbersome . HepQuant , LLC develop platform test liver function include Systemic Hepatic Filtration Rate ( HFR ) , Portal HFR , SHUNT , Disease Severity Index ( DSI ) 1,2 . HepQuant test specifically target hepatic uptake cholate use single noninvasive test 90 minute duration quantify systemic circulation , portal circulation , portal-systemic shunt derive DSI intact human subject . HepQuant test assess stage etiology liver disease . In chronic HCV patient HepQuant test predict patient respond antiviral therapy measure improvement hepatic function occur successful antiviral therapy . Patients respond follow average 5 year 8 year , baseline HepQuant testing could predict clinical outcome ( CTP progression , variceal bleeding , encephalopathy , ascites , liver-related death ) 87 % sensitivity 71 % specificity .</brief_summary>
	<brief_title>Liver Function Measured HepQuant-SHUNT Prediction Outcomes Patients With Heart Disease</brief_title>
	<detailed_description>Hypothesis The result HepQuant patient CHD correlate outcome cardiac surgery ( namely morbidity define complication ischemic hepatitis , survival , need heart transplantation , improvement liver function post revision ) , thus use prognosis condition , either alone conjunction clinical , physiological , laboratory prognostic score , thereby give clinical guidance concern need heart transplantation simultaneous liver transplantation.. Primary Aim To assess relationship HepQuant testing result clinical outcome patient liver disease secondary congenital heart disease ( CHD ) undergo Fontan revision . To assess clinical outcome patient liver disease secondary acquire cardiomyopathy valvular disease undergo extensive heart surgery heart transplantation . Secondary Aim To assess whether HepQuant test predicts clinical outcome patient Liver Disease CHD use conjunction diagnostic test , MELD , Child-Turcotte-Pugh ( CTP ) , liver stiffness measurement ( US ARFI ) , Fibrotest ( Fibrosure ) . Study population Male female Subjects ( age 18 70 year ) liver disease secondary congenital heart disease cardiomyopathy .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>1 . Written inform consent obtain prior studyspecific assessment . 2 . Liver disease secondary congenital heart disease cardiomyopathy . 3 . Male female subject ( age 18 70 year age ) . 1 . Male female subject &lt; 18 &gt; 70 year age . 2 . Female subject childbearing potential pregnant breast feeding . 3 . Subjects beta blocker ACE inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Liver disease</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>congenital heart disease</keyword>
</DOC>